Diseases, Conditions, Syndromes

An antiviral gel may prevent genital herpes in women

In a paper recently published in the Journal of Infectious Diseases, researchers examined the effect of vaginal tenofovir 1 percent gel use on the risk of acquiring herpes simplex virus type 2, or HSV-2. The study was conducted ...

HIV & AIDS

Anti-HIV gel being evaluated in pregnant and breastfeeding women

Determining whether a promising HIV prevention gel is safe for women to use while they are pregnant or breastfeeding is the aim of a new clinical trial being conducted by the National Institutes of Health-funded Microbicide ...

HIV & AIDS

AIDS: HIV drugs boost prevention hopes

Heterosexuals who take daily AIDS drugs reduce the risk of being infected by the human immunodeficiency virus (HIV) by nearly two-thirds, ground-breaking studies said on Wednesday.

HIV & AIDS

HIV trial scrapped after gel found to be ineffective

In a major setback for AIDS prevention research, a clinical trial of a new vaginal gel supposed to reduce HIV infections has been suspended after studies showed it to be ineffective.

HIV & AIDS

Some vaginal bacteria may weaken anti-HIV gel: study

Some kinds of vaginal bacteria may interfere with a gel meant to curb the risk of contracting HIV, which infects more than one million women worldwide each year, researchers said Thursday.

Diseases, Conditions, Syndromes

Hepatitis B virus reemerges with long-term nucleoside analog treatment

A recently published study revealed that virological breakthrough (VBT) is common in patients receiving nucleoside analogs (NUCs) for chronic hepatitis B. Nearly 40% of the VBTs found were not related to antiviral drug resistance. ...

page 1 from 5